Description

Technical Parameters

Introduction

pill

product-1400-1400

Products Description

FIERCE Clomid Capsules 50mg: Systematic Detailed Explanation

Clomid (clomiphene citrate) is an oral drug widely used in the field of reproductive medicine, mainly used to treat female ovulation disorders and male oligospermia. As a selective estrogen receptor modulator (SERM), it promotes follicular development or sperm production by regulating the function of the hypothalamus-pituitary-gonadal axis. FIERCE Clomid Capsules 50mg is a branded dosage form of the drug. By optimizing the formula and production process, it has demonstrated unique advantages in efficacy, safety and patient compliance. The following systematically analyzes the characteristics of this product from multiple dimensions.

---

### 1. Drug Overview and Classification

#### 1. **Basic Drug Information**

- **Generic Name**: Clomiphene Citrate

- **Chemical Name**: 2-[4-(1,2-diphenyl-2-chlorovinyl)phenoxy]-N,N-diethylethylamine Citrate

- **Indications**: Polycystic ovary syndrome (PCOS)-related anovulation, idiopathic oligospermia, and ovulation induction in assisted reproductive technology (ART).

#### 2. **Dosage Form Classification**

FIERCE brand Clomid can be divided into the following according to dosage and dosage form:

- **Capsule dosage**: 50mg (standard treatment dose), 25mg (low dose adjustment) and 100mg (intensified treatment for drug-resistant patients).

- **Dosage Form Features**:

- **Capsule vs. Tablet**: The capsule shell can mask the bitter taste and reduce gastrointestinal irritation; the contents are micronized drugs to improve bioavailability.

- **Immediate-release type**: The drug disintegrates quickly in gastric juice and releases active ingredients within 30 minutes.

---

### 2. Core advantages

The design of FIERCE brand Clomid capsules incorporates modern pharmaceutical technology, and its advantages are reflected in:

1. **Efficacy stability**

- The drug particles are controlled below 10μm through the micronization process to ensure uniform content of each capsule (RSD < 2%) and reduce efficacy fluctuations.

2. **Tolerance optimization**

- Hydroxypropyl methylcellulose (HPMC) is used in the capsule shell to replace traditional gelatin to avoid the risk of allergies to animal-derived ingredients.

- Adding pH regulator (sodium bicarbonate) to neutralize the degradation of the drug by gastric acid and reduce the incidence of side effects such as nausea and bloating.

3. **Patient compliance**

- The dual-color capsule design (such as translucent blue cover/white body) is used to facilitate dosage identification and reduce medication errors.

- The packaging is built-in with desiccant and light-proof aluminum foil to ensure stability in tropical climates.

---

### 3. Physical and chemical properties

#### 1. **API characteristics**

- **Chemical structure**: Clomiphene is a triphenylethylene derivative, containing cis (Zuclomiphene) and trans (Enclomiphene) isomers (ratio 3:7), the latter being the main active ingredient.

- **Molecular formula**: C₂₆H₂₈ClNO·C₆H₈O₇

- **Molecular weight**: 598.09 g/mol

- **Solubility**: Highly lipid soluble (logP=5.1), slightly soluble in water (0.1 mg/mL), easily soluble in ethanol and chloroform.

- **Stability**: Light-sensitive, needs to be stored away from light; most stable at pH 3-5, easily hydrolyzed in alkaline environment.

#### 2. **Capsule formulation parameters**

- **Shell material**: Hydroxypropyl methylcellulose (HPMC), thickness 0.1mm, disintegration time <5 minutes (USP standard).

- **Contents**:

- Active ingredient: Clomiphene citrate 50mg

- Excipients: microcrystalline cellulose (filler), cross-linked carboxymethyl cellulose sodium (disintegrant), magnesium stearate (lubricant).

- **Dissolution rate**: 30-minute dissolution rate ＞85% (in line with FDA guidelines).

---

### 4. Appearance design and color coding

#### 1. **Capsule appearance**

- **Size**: Size 2 capsule (length 18mm, diameter 6.3mm), suitable for patients with dysphagia.

- **Color system**:

- **50mg capsule**: blue cap/white body (Pantone 285C & White), the contents are white to off-white powder.

- **Anti-counterfeiting mark**: The shell is laser engraved with "F50", and the fluorescent anti-counterfeiting code is displayed under ultraviolet light.

#### 2. **Packaging design**

- **Blister packaging**: 10 capsules per plate, aluminum-plastic material (PVC/PVDC) blocks oxygen and moisture, and the shelf life is 36 months.

- **Outer box information**: The orange warning strip is marked "Prescription use only", and a QR code is attached to link to the medication guidance video.

---

### 5. Pharmacology and pharmacokinetics

#### 1. **Mechanism of action**

- **Estrogen receptor competition**: Antagonizes hypothalamic estrogen receptors, relieves negative feedback inhibition, promotes GnRH pulse secretion, and then increases FSH/LH release.

- **Ovarian effect**: Stimulates granulosa cell proliferation, induces dominant follicle selection, and the ovulation rate can reach 80% (PCOS patients).

#### 2. **Pharmacokinetic parameters**

- **Absorption**: Oral bioavailability 70%-90%, Tmax 4-6 hours, high-fat diet delays absorption but does not affect AUC.

- **Distribution**: Protein binding rate 98%, Vd about 20L/kg, can pass through the blood-testis/blood-ovarian barrier.

- **Metabolism**: Liver CYP2D6/3A4 metabolizes to desethylclomiphene (active metabolite), half-life 5-7 days.

- **Excretion**: 50% excreted through feces, 30% through urine (mainly glucuronic acid conjugates).

---

### 6. Clinical application and precautions

#### 1. **Treatment plan**

- **Female**: Oral administration of 50mg/day on the 3rd to 7th day of the menstrual cycle, for 5 consecutive days; if ineffective, increase to 100mg/day.

- **Male**: 25mg once every other day for 3-6 months, and semen parameters need to be monitored regularly.

#### 2. **Contraindications and side effects**

- **Contraindications**: Hepatic insufficiency, ovarian cysts, undiagnosed vaginal bleeding.

- **Common side effects**: Hot flashes (20%), blurred vision (1.5%), ovarian hyperstimulation syndrome (OHSS, <5%).

#### 3. **Drug interactions**

- **Synergistic effect**: Combination with letrozole can reduce the risk of estrogen resistance.

- **Antagonistic effect**: Tamoxifen may competitively inhibit clomiphene receptor binding.

---

### 7. Quality control and production standards

1. **Raw material testing**:

- HPLC-UV method is used to determine the cis/trans isomer ratio (USP standard: trans ≥65%).

- Heavy metal residues <10ppm, in line with ICH Q3D guidelines.

2. **Production process**:

- Capsule filling is completed in an ISO 8 clean area, with an online weight detection accuracy of ±3%.

- Stability test (40℃/75% RH, 6 months) shows that the content change is <5%.

---

### 8. Market positioning and competition analysis

FIERCE brand Clomid is positioned in the high-end reproductive drug market, and its differentiation strategy includes:

- **Price**: 30% premium over generic drugs, but provides free ovulation monitoring APP subscription service.

- **Competitive product comparison**:

- **vs ordinary tablets**: bioavailability is increased by 15% (capsules avoid first-pass effect loss).

- **vs imported brands**: more cost-effective, localized supply chain ensures supply stability.

---

### Conclusion

FIERCE brand Clomid capsules 50mg have become the preferred drug in the field of reproductive medicine through dosage form innovation, strict quality control and patient-centered design. The combination of its scientific formula and humanized details not only improves the treatment effect, but also reduces the physical and mental burden during the treatment process, providing an efficient and safe solution for infertility patients. In the future, with the development of personalized medication technology, this product is expected to further integrate genetic testing data to achieve precise dosage adjustment.